IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6097-6104

  Celestin, J ^a   Rotschke, O ^a   Falk, K ^a   Ramesh, N ^a   Jabara, H ^a   Strominger, J ^a   Geha, R S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 3; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; SUPERANTIGEN; SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN 1; TETANUS TOXOID; TOXIN; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL CLONE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NORMAL HUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0035575733     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6097     Document Type: Article

References (51)

1. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes
2. The B7 and CD28 receptor families
3. New perspectives of CD28-B7-mediated T cell costimulation
4. T-cell co-stimulation through B7RP-1 and ICOS
5. B7-HI, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
6. Differential T cell costimulatory requirements in CD28-deficient mice
7. Interieukin-7 specifically induces the B7/BB1 antigen on human cord blood and peripheral blood T cells and T cell clones
8. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10
9. Interleukin-1 but not turnout necrosis factor α synergistically upregulates the granulocyte-macrophage colonystimulating factor-induced B7-1 expression of murine Langerhans cells
10. Differential up-regulation of the B7-B1 and B7-2 costimulatory molecules after lg receptor engagement by antigen
11. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal
12. CD40 ligation induced phenotypic and functional expression of CD80 by human cardiac microvascular endothelial cells
13. The eosinophilic leukocyte: Structure and function
14. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR
15. Accessory cell function of human eosinophils
16. Mature human eosinophils have the capacity to express HLA-DR
17. Human eosinophils as antigen-presenting cells: Relative efficiency for superantigen- and antigen-induced CD4T-cell proliferation
18. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia
19. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type I cytokines (interleukin 2 and interferon γ): Inhibition by immunoglobulin a complexes
20. Lymph node trafficking and antigen presentation by endobronchial eosinophils
21. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils
22. Eosinophil as antigen-presenting cell: Activation of T cell clones and T cell hybridoma by eosinophils after antigen processing
23. Interleukin-3: Molecular biology and biologic activities
24. Interleukin-3 is a differentiation factor for human basophils
25. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3
26. Molecular cloning and biological characterization of human interleukin-3 (IL-3)
27. Interleukin-3 production by mast cells from human lung
28. + T cell lines in atopic asthmatics and atopic and nonatopic controls
29. Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma
30. Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps
31. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils
32. Antigenspecific T lymphocyte clones: Viral antigen specificity of influenza virus-immune clones
33. Recognition by a human alloreactive T-cell clone of an HLA-DP-associated epitope on monocytes and fibroblasts but not on B cells
34. Superantigens interact with MHC class II molecules outside of the antigen groove
35. Toxic shock syndrome toxin I binds to major histocompatibility complex class II molecules
36. Vβ-specific stimulation of human T cells by staphylococcal toxins
37. Binding of a soluble ab T-cell receptor to superantigen/major histocompatibility complex ligands
38. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity
39. Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7
40. T cell derived cytokines in lung-phase immunity to Schislosoma mansoni
41. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells
42. B7-1 and B7-2 Costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
43. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
44. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?
45. B7.2 provides co-stimulatory functions in vivo in response to staphylococcal enterotoxin B
46. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines
47. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: Costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1
48. Pathogenesis of atopic dermatitis
49. Eosinophils in asthma and other allergic diseases
50. Reactive hypereosinophilia in parasitic diseases
51. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens